A new cancer protein solubility tool: Entropic Bristle

Information

  • Research Project
  • 7939240
  • ApplicationId
    7939240
  • Core Project Number
    R44CA110548
  • Full Project Number
    3R44CA110548-03S1
  • Serial Number
    110548
  • FOA Number
    PA-07-280
  • Sub Project Id
  • Project Start Date
    9/30/2009 - 15 years ago
  • Project End Date
    6/30/2011 - 13 years ago
  • Program Officer Name
    ANDALIBI, ALI
  • Budget Start Date
    9/30/2009 - 15 years ago
  • Budget End Date
    6/30/2011 - 13 years ago
  • Fiscal Year
    2009
  • Support Year
    3
  • Suffix
    S1
  • Award Notice Date
    9/30/2009 - 15 years ago
Organizations

A new cancer protein solubility tool: Entropic Bristle

DESCRIPTION (provided by applicant): Expression and purification of cancer-associated proteins are prerequisite steps necessary to study their functions, structures, and interactions. However, these steps are often challenging or even infeasible due to poor protein solubility. This project seeks to develop a tool, a set of entropic bristle-based AquoProtTM vectors, to dramatically increase the fraction of cancer-related proteins that can be expressed and purified in vitro, thus improving the success rate of functional analysis efforts for commercial and academic applications. Therefore, AquoProtTM benefit cancer research by enabling researchers to successfully purify and study many cancer-associated proteins that were not soluble with other technologies. This demand in novel solubiluization technologies is expected to grow in the market as proteomics projects proliferate, and as researchers are faced with the additional need to express recalcitrant proteins. The overall project aim is to develop a set of entropic bristle domain (EBD) fusion vectors, AquoProtTM kits that will be used to increase the solubility of many types of recombinant cancer-related proteins. The term "entropic bristle" describes a highly flexible, non-aggregating polymer chain. The feasibility and effectiveness of the EBD fusions for solubilizing proteins previously characterized were successfully proven in Phase I extension research. Phase II is dedicated to the creation of the AquoProtTM vector, the expansion of the product line to develop a set of AquoProtTM vectors, the assembly of the prototype AquoProtTM kit, and the elaboration of the kit production cycle. The set of EDB-based AquoProtTM kits proposed here is a totally novel approach to attack the problem of cancer-related protein insolubility, whether it be a single protein or multiple targets. These solubility-enhancing kits will increase the utility of systems for cancer protein over-expression. It is necessary to emphasize that protein insolubility is a general and wide spread phenomenon. It slows down or makes completely infeasible studies on many proteins in pharmaceutical, agro-biochemical, biotechnological and academic laboratories and institutions. Therefore a set of vectors aimed at the enhancement of protein solubility will be of benefit for any researcher facing the insolubility problem. Public Health Relevance: Expression and purification of cancer-associated proteins are prerequisite steps necessary to study their functions, structures, and interactions. However, these steps are often challenging or even infeasible due to poor protein solubility. This project seeks to develop a tool, a set of entropic bristle-based AquoProtTM vectors, to dramatically increase the fraction of cancer-related proteins that can be expressed and purified in vitro, thus improving the success rate of functional analysis efforts for commercial and academic applications. Therefore, AquoProtTM benefit cancer research by enabling researchers to successfully purify and study many cancer-associated proteins that were not soluble with other technologies.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    199962
  • Sub Project Total Cost
  • ARRA Funded
    True
  • CFDA Code
    701
  • Ed Inst. Type
  • Funding ICs
    NCI:199962\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MOLECULAR KINETICS, INC.
  • Organization Department
  • Organization DUNS
    183789163
  • Organization City
    INDIANAPOLIS
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    46268
  • Organization District
    UNITED STATES